Development of human monoclonal antibodies to diphtheria toxin: A solution for the increasing lack of equine DAT for therapeutic use?

1. Wagner KS, White JM, Lucenko I, Mercer D, Crowcroft NS, Neal S, Efstratiou A. Diphtheria in the postepidemic period, Europe, 2000-2009.. Emerg Infect Dis 2012 Feb;18(2):217-25.
   doi: 10.3201/eid1802.110987pmc: PMC3310452pubmed: 22304732google scholar: lookup
2. Wagner KS, Stickings P, White JM, Neal S, Crowcroft NS, Sesardic D, Efstratiou A. A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use.. Vaccine 2009 Dec 10;28(1):14-20.
   doi: 10.1016/j.vaccine.2009.09.094pubmed: 19818425google scholar: lookup
3. Kakita M, Takahashi T, Komiya T, Iba Y, Tsuji T, Kurosawa Y, Takahashi M. Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin.. Infect Immun 2006 Jun;74(6):3682-3.
   doi: 10.1128/IAI.01731-05pmc: PMC1479265pubmed: 16714603google scholar: lookup
4. Sevigny LM, Booth BJ, Rowley KJ, Leav BA, Cheslock PS, Garrity KA, Sloan SE, Thomas W Jr, Babcock GJ, Wang Y. Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.. Infect Immun 2013 Nov;81(11):3992-4000.
   doi: 10.1128/IAI.00462-13pmc: PMC3811848pubmed: 23940209google scholar: lookup
5. Smith HL, Cheslock P, Leney M, Barton B, Molrine DC. Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model.. Virulence 2016 Aug 17;7(6):660-8.
   doi: 10.1080/21505594.2016.1171436pmc: PMC4991329pubmed: 27070129google scholar: lookup
6. Scheifele DW, Ochnio JJ. The immunological basis for immunization series/module 2: diphtheria update 2009. [pp. 1-28]; WHO.
7. Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, Hallander HO, Olander R, Maple PA, Melker HE, Olin P, Fievret-Groyne F, Rota C, Salmaso S, Tischer A, von-Hunolstein C, Miller E. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.. Epidemiol Infect 2000 Aug;125(1):113-25.
   doi: 10.1017/S0950268899004161pmc: PMC2869577pubmed: 11057967google scholar: lookup
8. Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.. Epidemiol Infect 2011 Apr;139(4):494-504.
   doi: 10.1017/S0950268810001536pubmed: 20587123google scholar: lookup
9. Swart EM, van Gageldonk PG, de Melker HE, van der Klis FR, Berbers GA, Mollema L. Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.. PLoS One 2016;11(2):e0148605.
   doi: 10.1371/journal.pone.0148605pmc: PMC4749226pubmed: 26863307google scholar: lookup
10. Huygen K, Caboré RN, Maertens K, Van Damme P, Leuridan E. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women.. Vaccine 2015 Aug 7;33(33):4117-23.
    doi: 10.1016/j.vaccine.2015.06.108pubmed: 26187257google scholar: lookup
11. Maertens K, Caboré RN, Huygen K, Hens N, Van Damme P, Leuridan E. Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study.. Vaccine 2016 Jan 2;34(1):142-50.
    doi: 10.1016/j.vaccine.2015.10.100pubmed: 26592142google scholar: lookup

Citations

1. Lan J, Zhang R, Li P, Chen J, Xie Z, Jiang S. Identification of a Type-Specific Epitope in the ORF2 Protein of Duck Astrovirus Type 1.. Animals (Basel) 2019 Dec 2;9(12).
   doi: 10.3390/ani9121069pubmed: 31810309google scholar: lookup
2. Rex JH, Fernandez Lynch H, Cohen IG, Darrow JJ, Outterson K. Designing development programs for non-traditional antibacterial agents.. Nat Commun 2019 Jul 31;10(1):3416.
   doi: 10.1038/s41467-019-11303-9pubmed: 31366924google scholar: lookup
3. Caboré RN, Maertens K, Dobly A, Leuridan E, Van Damme P, Huygen K. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.. Virulence 2017 Oct 3;8(7):1245-1254.
   doi: 10.1080/21505594.2017.1296998pubmed: 28277900google scholar: lookup